Collateral for a security interest recorded Apr 27, 2026 (Citibank, N.A.).
Term ends May 16, 2027 · Low confidence
20-year base term ends May 16, 2027
Held by BPCR Limited Partnership
Filed Sep 9, 2019 as application 16/564,694 · Granted Feb 8, 2022
Base term plus 38 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2007
2027
Clock starts
May 16, 2007
May 16, 2007
Term ends
May 16, 2027
May 16, 2027
Granted
Feb 8, 2022
Feb 8, 2022
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
38
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,406,143, US 9,000,011, US 9,480,682, US 9,987,263.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 38 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 1 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 16, 2007, when application 11/749,512, the earliest non-provisional in its chain, was filed (this one was filed Sep 9, 2019); a parent in its chain could not be resolved (the next row) | May 16, 2027 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +38 days, USPTO patent term adjustment record | Jun 23, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,406,143, US 9,000,011, US 9,480,682, US 9,987,263) | capped to May 16, 2027 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | May 16, 2027 | Low confidence |
This family
| US 7,851,143 | In force May 2027 | May 2027 |
| Application 12/966,904 | Abandoned not computed | not computed |
| US 9,000,011 | In force May 2027 | May 2027 |
| US 9,480,682 | In force May 2027 | May 2027 |
| US 9,987,263 | In force no later than May 2027 | no later than May 2027 |
| US 10,406,143 | In force (reinstated) May 2027 | May 2027 |
| US 10,383,864 | In force May 2027 | May 2027 |
| US 11,241,422 | this patent May 2027 | May 2027 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 11, 2020 Reel 52625, frame 916 | Amicus Therapeutics, Inc. | Biopharma Credit PLC | Security Interest |
| May 21, 2020 Reel 52741, frame 173 | Biopharma Credit PLC | BPCR Limited Partnership | Omnibus Confirmation of Assignment Agreement |
| Jul 30, 2020 Reel 53360, frame 659 | BPCR Limited Partnership | Amicus Therapeutics, Inc. | Release of Security Interest |
| Jul 30, 2020 Reel 53365, frame 342 | Amicus Therapeutics, Inc. | Hayfin Services LLP, as Agent | Security Interest |
| Oct 6, 2023 Reel 65177, frame 196 | Amicus Therapeutics, Inc. | Wilmington Trust, National Association | Security Interest |
| Oct 6, 2023 Reel 65164, frame 945 | Hayfin Services LLP | Amicus Therapeutics, Inc. | Release of Security Interest |
| Apr 27, 2026 Reel 75493, frame 968 | Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 27, 2026 Reel 75494, frame 30 | Wilmington Trust, National Association | Amicus Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
May 2027
Term ends May 16, 2027. No further fees fall due before then
Note
The 38 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,406,143, US 9,000,011, US 9,480,682, US 9,987,263.
Citations
53
later US patents cite this one
That is top 5% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.